|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2023―Dec―07 |
Budget impact of oral nirmatrelvir/ritonavir in adults at high risk for progression to severe COVID-19 in the United States |
Rickard Sandin, David L. Veenstra, Mathilde Vankelegom, Mendwas Dzingina, Sean D. Sullivan, David Campbell, et al. (+5) Cuiying Ma, Cale Harrison, Florin Draica, Timothy Lee Wiemken, Tendai Mugwagwa |
2 |
[GO] |
2023―Mar―29 |
Prevalence of potential drug-drug interactions with ritonavir-containing COVID-19 therapy |
Ebuwa Igho-Osagie, Amy Puenpatom, Marissa Grifasi Williams, Yan Song, Denise Yi, Jessie Wang, et al. (+3) Richard Berman, Miley Gu, Chujun He |
3 |
[GO] |
2023―Jan―13 |
Within-trial economic analysis of resource use from COMET-ICE: A phase 3 clinical trial evaluating sotrovimab for the treatment of patients with COVID-19 at high risk of progression |
Tasneem Lokhandwala, Mahip Acharya, Eileen Farrelly, Anna D Coutinho, Christopher F Bell, Henrik Svedsater |
4 |
[GO] |
2023―Jan―13 |
COVID-19 and adherence to biologic therapies for psoriasis: An analysis of nationwide pharmacy claims data |
Meiqi He, Laura K Ferris, Nico Gabriel, Mina Tadrous, Inmaculada Hernandez |
5 |
[GO] |
2023―Jan―13 |
Direct health care costs associated with COVID-19 in the United States |
Jessica K DeMartino, Elyse Swallow, Debbie Goldschmidt, Karen Yang, Marta Viola, Tyler Radtke, Noam Kirson |
6 |
[GO] |
2023―Jan―13 |
Impact of the COVID-19 pandemic on hepatitis C outcomes at a health-system specialty pharmacy |
Megan Pendley Cooper, Heather Foley, David Damico, Maribeth Wright, Christian Rhudy, Aric Schadler, Thom Platt |
7 |
[GO] |
2023―Jan―13 |
Oral treatments for outpatient COVID-19: Effectiveness and value |
Molly Beinfeld, Kai Yeung, Melanie D Whittington, Rasheed Mohammed, Emily Nhan, Steven D Pearson |
8 |
[GO] |
2022―Nov―25 |
COVID-19 vaccination and race - A nationwide survey of vaccination status, intentions, and trust in the US general population |
Carolyn Brown, Amy Morlock, Karin Blakolmer, Elham Heidari, Robert Morlock |
9 |
[GO] |
2022―Apr―28 |
Patient perspectives and use of copayment assistance during the COVID-19 pandemic |
William B Wong, Kimberly Jinnett |
10 |
[GO] |
2022―Mar―03 |
Cost-effectiveness of casirivimab/imdevimab in patients with COVID-19 in the ambulatory setting |
Nick Jovanoski, Andreas Kuznik, Ursula Becker, Mohamed Hussein, Andrew Briggs |
11 |
[GO] |
2021―Oct―01 |
Drug-dispensing limits within Medicaid during the COVID-19 pandemic |
Jonathan D Alpern, Nathan Chomilo, Malini DeSilva |
12 |
[GO] |
2021―Sep―17 |
The effect of unobserved preferences and race on vaccination hesitancy for COVID-19 vaccines: implications for health disparities |
Eline M van den Broek-Altenburg, Adam J Atherly, Stephane Hess, Jamie Benson |
13 |
[GO] |
2020―Jul―27 |
COVID-19 and Drug Shortages: A Call to Action |
Andrew G. Shuman, Erin R. Fox, Yoram Unguru |